Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD
Med Page Today
MAY 24, 2024
(MedPage Today) -- For people with type 2 diabetes and chronic kidney disease (CKD), semaglutide (Ozempic) reduced the risk of major kidney events and death from cardiovascular causes, the phase III FLOW trial showed. Added to usual care, the.
Let's personalize your content